Skip to content

The Effect of Maoci on Lower Limb Motor Function in Stroke Patients and Neuro Network Research

The Effect of Maoci on Lower Limb Motor Function in Stroke Patients and Neuro Network Research

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000058
Enrollment
Unknown
Registered
2026-01-13
Start date
2026-04-06
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Sponsors

Longyan City Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18–80 years, gender; (2) Confirmed diagnosis of ischemic or hemorrhagic stroke, with lesions confirmed by CT or MRI imaging; (3) Disease duration of 1 month (=28 days) and =6 months (subacute to early chronic stage), with no progressive neurological deterioration; (4) Hemiplegia of one lower limb, with significant weakness in dorsiflexion of the foot or hip flexion (subjective/objective evidence): Lower limb Fugl–Meyer score (FMA-LL) between 10–25 points; (5) Able to understand and cooperate to perform simple movements and testing tasks (able to complete dorsiflexion or leg-lifting movements as instructed), or able to complete passive-active tasks with physical assistance; (6) Stable rehabilitation and medical treatment for more than 2 weeks, willing to sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive or language impairments that prevent understanding or cooperation with the testing tasks; 2. History of severe lower limb bone-joint diseases, tendon ruptures, or peripheral neuropathy, where the cause of functional impairment is not central; 3. Skin breakdown, infection, ulcers, or severe local circulatory impairment at the lesion site, making acupuncture manipulation unsuitable; 4. Severe spasticity or extremely high muscle tone, or obvious tendon contractures that prevent standardized tasks from being performed; 5. Presence of implantable cardiac pacemakers, defibrillators, or other devices contraindicated for electrical stimulation, or other devices that conflict with sEMG or electrophysiological equipment; 6. Pregnant or breastfeeding women; 7. Severe cardiopulmonary insufficiency, hepatic or renal failure, active bleeding, or coagulation disorders, or other severe systemic diseases; 8. Receipt of acupuncture, micro-needle, or electrical stimulation interventions targeting the same area within the past month, or current participation in other interventional clinical trials; 9. intolerance or allergy to acupuncture; 10. Other conditions deemed unsuitable for participation in this study by the investigator.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Motor Function Assessment;Average Electromyographic Value, Integral Electromyographic Value, Synergistic Contraction Rate;Hmax, Mmax/Hmax, F-wave amplitude, F-wave latency;GLM Fitting and Analysis, Beta Value;

Secondary

MeasureTime frame
Load-bearing symmetry, stride deviation, joint flexion-extension angle symmetry;

Countries

China

Contacts

Public ContactQue Xiuqin

Longyan City Traditional Chinese Medicine Hospital

513090632@qq.com13859583177

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026